The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: A multivariate analysis

被引:34
作者
Hubain, PP
Staner, L
Dramaix, M
Kerkhofs, M
Papadimitriou, G
Mendlewicz, J
Linkowski, P
机构
[1] Univ Brussels, Erasme Hosp, Dept Psychiat, B-1070 Brussels, Belgium
[2] Ctr Hosp, Dept Psychiat, Luxembourg, Luxembourg
[3] Univ Brussels, Sch Publ Hlth, Dept Biostat, Brussels, Belgium
[4] Univ Athens, Sch Med, Dept Psychiat, GR-11527 Athens, Greece
关键词
stress; major depressive disorder; DST; sleep; overarousal; Hamilton Rating Scale for Depression;
D O I
10.1016/S0006-3223(97)80434-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The present study further examined relationships between postdexamethasone cortisol plasma values and sleep electroencephalogram (EEG) parameters. Methods: The dexamethasone suppression test (DST) and polysomnographic recordings were performed in a sample of 300 inpatients with primary major depressive disorder (MDD) (102 men and 198 women, mean age 44 +/- 12 years, range 20-74 years) consecutively admitted to Erasme Hospital (Brussels, Belgium) between 1981 and 1992. Results: The DST was abnormal in 40% of the sample. Postdexamethasone cortisol plasma values at 4:00 PM were significantly influenced by age, but not by gender. They were also significantly and positively correlated with weight loss, total scares on the Hamilton Depression Rating Scale, total scores on the Newcastle Scale, percentage of awakenings during sleep, and percent of stage 1. They were significantly and negatively correlated with percent of stage 2, slow-wave sleep, and REM sleep. Multiple regression analyses were conducted in two successive steps. First among clinical variables, only age and depressive symptom severity remained correlated with postdexamethasone plasma cortisol values. In the second step, with age and severity held constant, postdexamethasone plasma cortisol values were positively associated with amount of wake time and stage 1, and negatively with amount of slow-wave sleep. Conclusions: These findings provide further indirect support for an overarousal state in MDD with sympathoadrenal system hyperactivity and impaired sleep continuity. They also underline the importance of taking into account various clinical confounding factors in the interpretation of both DST and sleep EEG results. (C) 1998 Society of Biological Psychiatry.
引用
收藏
页码:220 / 229
页数:10
相关论文
共 82 条
[21]  
DEVANAND DP, 1991, ARCH GEN PSYCHIAT, V48, P525
[22]  
Dinan TG, 1996, J CLIN PSYCHIAT, V57, P14
[23]  
FEINBERG M, 1984, ARCH GEN PSYCHIAT, V41, P1080
[24]   POLYSOMNOGRAPHIC FINDINGS AND DEXAMETHASONE NONSUPPRESSION IN UNIPOLAR DEPRESSION - A REPLICATION AND EXTENSION [J].
GILES, DE ;
SCHLESSER, MA ;
RUSH, AJ ;
ORSULAK, PJ ;
FULTON, CL ;
ROFFWARG, HP .
BIOLOGICAL PSYCHIATRY, 1987, 22 (07) :872-882
[25]   AGE-RELATED-CHANGES IN SLEEP IN DEPRESSED AND NORMAL SUBJECTS [J].
GILLIN, JC ;
DUNCAN, WC ;
MURPHY, DL ;
POST, RM ;
WEHR, TA ;
GOODWIN, FK ;
WYATT, RJ ;
BUNNEY, WE .
PSYCHIATRY RESEARCH, 1981, 4 (01) :73-78
[26]  
Guy W., 1976, Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville, MD, U.S. Department of Health, Education, and Welfare, Public health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, DHEW Publ No ADM 76-338, pp 218-222., P218
[27]  
HOES MJA, 1985, HDB CLIN NEUROLOGY, V1, P245
[28]   EFFECTS OF INTRAVENOUS CORTICOTROPIN-RELEASING HORMONE UPON SLEEP-RELATED GROWTH-HORMONE SURGE AND SLEEP EEG IN MAN [J].
HOLSBOER, F ;
VONBARDELEBEN, U ;
STEIGER, A .
NEUROENDOCRINOLOGY, 1988, 48 (01) :32-38
[29]   THE DEXAMETHASONE SUPPRESSION TEST IN AFFECTIVE ILLNESSES AND SCHIZOPHRENIA - RELATIONSHIP WITH PSYCHOTIC SYMPTOMS [J].
HUBAIN, PP ;
SIMONNET, MP ;
MENDLEWICZ, J .
NEUROPSYCHOBIOLOGY, 1986, 16 (2-3) :57-60
[30]   TSH RESPONSE TO TRH AND EEG SLEEP IN NON-BIPOLAR MAJOR DEPRESSION - A MULTIVARIATE APPROACH [J].
HUBAIN, PP ;
STANER, L ;
DRAMAIX, M ;
KERKHOFS, M ;
VANVEEREN, C ;
PAPADIMITRIOU, G ;
MENDLEWICZ, J ;
LINKOWSKI, P .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1994, 4 (04) :517-525